Patent · US Active

Modified immunization vectors

US9670506B2 · kind B2 · utility

18Cited by
28References
17Claims
0Family size

Assignees

Inventors

Key dates

Filing dateApr 29, 2010
Grant dateJun 6, 2017
Priority date—
Expiry dateMar 30, 2031

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The disclosure relates to recombinant vectors and methods for using the same. In certain embodiments, the recombinant vectors are immunogenic.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.